Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

• The global vascular grafts market size reached USD 2.0 Billion in 2024.
• The market is expected to reach 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.
• North America leads the market, accounting for the largest vascular grafts market share.
• Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.
• Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.
• The ongoing technological advancements in graft materials and design are supporting the market growth.
• The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

• Prevalence of Cardiovascular Diseases:

This sector’s growth is, therefore, fuelled by the growing global incidences of cardiovascular diseases (CVDs). These diseases usually require operations that employ vascular grafts.

• Technological Advancements in Graft Materials and Design:

Dedicated improvements in graft related products have led to an upsurge in the market. Current generation of vascular grafts is non-thrombogenic, non-immunogenic, and long lasting and have minimal adverse effects like infection and rejection. Drug eluting and tissue engineered grafts are also coming up so on. These grafts should be less rejected by the body compared to the current ones used that are more mechanical in their property. They are also used in improving vascular surgeries, and thereby improving the experiences of patient.

• Preference for Minimally Invasive Surgeries (MIS):

Market growth has been boosted by minimally invasive surgeries (MIS). Surgical therapies that are less invasive than can include Endovascular aneurysm repair (EVAR) and Thoracic Endovascular aneurysm repair (TEVAR). They also decrease the number of hospitalizations, lower the likelihood of getting sick and expedite the healing process. It is this, which creates interest in specific vascular grafts required for these surgeries. Also, there is a shift towards MIS among patient-physician relationships Forest & Taylor (2006). This trend rises the need for similarly aligned vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

• Endovascular Stent Grafts
• Hemodialysis Access Grafts
• Coronary Artery By-Pass Grafts
• Vascular Grafts for Aorta Disease
• Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

By Raw Material:

• Polytetrafluoroethylene (PTFE)
• Polyester
• Polyurethane
• Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

• Cardiac Aneurysm
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

The vascular grafts market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Abbott Laboratories
• B. Braun SE (B. Braun Holding GmbH & Co. KG)
• Becton, Dickinson & Company
• Cook Group Incorporated
• Cordis
• CryoLife Inc.
• Getinge AB
• Heat Medical Europe BV
• LeMaitre Vascular
• Medtronic plc
• Terumo Corporation
• W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145